ART-hero-image-1920
The_Logistics_of_a_Clinical_Study_ Scale-Up_Title_Card_d01

 

The Logistics of a Clinical Study Scale-up

Scaling up from phase 1 to global phase II/III trials to beyond marketing approval has several implications on a sponsor’s commercial strategy. Hear from Rachel Smith, Portfolio Director for Veristat, as she uses our recent work with a biotech company to illustrate the importance of a comprehensive shipping and traceability strategy, tight management of the patient journey, and adoption of a well-conceived protocol and process documentation to support the commercialization strategy.

 

 


Play another episode from our library

ART_logo_reversed_horizontal_stacked


Listen and subscribe on your favorite podcast player

  apple-podcast-badge EN_Google_Podcasts_Badge_1x spotify-podcast-badge-blk-grn-330x80 

  • Privacy Policy

© 2023 Veristat, Inc. All Rights Reserved.

Return to Top